Rapid resolution of migraine symptoms after initiating the preventive treatment eptinezumab during a migraine attack: results from the randomized RELIEF trial (vol 22, 205, 2022)

被引：0
|
作者：
Ailani, Jessica [1 ]
Mcallister, Peter [2 ]
Winner, Paul K. [3 ]
Chakhava, George [4 ]
Josiassen, Mette Krog [5 ]
Lindsten, Annika [5 ]
Sperling, Bjorn [5 ]
Ettrup, Anders [5 ]
Cady, Roger [6 ,7 ]
机构：
[1] Georgetown Univ Hosp, Dept Neurol, Washington, DC USA
[2] New England Inst Neurol & Headache, Stamford, CT USA
[3] Palm Beach Headache Ctr, W Palm Beach, FL USA
[4] DTvildiani Med Univ, Multiprofile Clin Consilium Medulla, Georgian Assoc Med Specialties, Tbilisi, Georgia
[5] H Lundbeck A S, Copenhagen, Denmark
[6] Lundbeck LLC, Deerfield, IL 60015 USA
[7] RK Consults, Ozark, MO 65721 USA
来源：
BMC NEUROLOGY | 2023年 / 23卷 / 01期
关键词：
D O I：
10.1186/s12883-023-03368-3
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 25 条
  • [1] Rapid resolution of migraine symptoms after initiating the preventive treatment eptinezumab during a migraine attack: results from the randomized RELIEF trial
    Ailani, Jessica
    McAllister, Peter
    Winner, Paul K.
    Chakhava, George
    Josiassen, Mette Krog
    Lindsten, Annika
    Sperling, Bjorn
    Ettrup, Anders
    Cady, Roger
    BMC NEUROLOGY, 2022, 22 (01)
  • [2] Rapid resolution of migraine symptoms after initiating the preventive treatment eptinezumab during a migraine attack: results from the randomized RELIEF trial
    Jessica Ailani
    Peter McAllister
    Paul K. Winner
    George Chakhava
    Mette Krog Josiassen
    Annika Lindsten
    Bjørn Sperling
    Anders Ettrup
    Roger Cady
    BMC Neurology, 22
  • [3] Correction: Rapid resolution of migraine symptoms after initiating the preventive treatment eptinezumab during a migraine attack: results from the randomized RELIEF trial
    Jessica Ailani
    Peter McAllister
    Paul K. Winner
    George Chakhava
    Mette Krog Josiassen
    Annika Lindsten
    Bjørn Sperling
    Anders Ettrup
    Roger Cady
    BMC Neurology, 23
  • [4] Rapid resolution of migraine symptoms after initiating the preventive treatment eptinezumab during a migraine attack
    McAllister, P.
    Winner, P. K.
    Chakhava, G.
    Josiassen, M.
    Lindsten, A.
    Ettrup, A.
    Sperling, B.
    Cady, R.
    Ailani, J.
    HEADACHE, 2021, 61 : 105 - 106
  • [5] Rapid Resolution of Migraine Symptoms After Initiating the Preventive Treatment Eptinezumab During a Migraine Attack
    Ailani, J.
    McAllister, P.
    Winner, P. K.
    Chakhava, G. G.
    Josiassen, M. K.
    Lindsten, A.
    Ettrup, A.
    Sperling, B.
    Cady, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 307 - 307
  • [6] Efficacy and Safety of Eptinezumab Initiated During a Migraine Attack: Results from the RELIEF Study
    Winner, Paul
    McAllister, Peter
    Chakhava, George
    Ailani, Jessica
    Mehta, Lahar
    Ettrup, Anders
    Josiassen, Mette Krog
    Lindsten, Annika
    Cady, Roger
    NEUROLOGY, 2021, 96 (15)
  • [7] Efficacy and Safety of Eptinezumab Initiated During a Migraine Attack: Results from the RELIEF Study
    Winner, P.
    McAllister, P.
    Chakhava, G.
    Ailani, J.
    Mehta, L.
    Ettrup, A.
    Josiassen, M.
    Lindsten, A.
    Cady, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 271 - 271
  • [8] Eptinezumab treatment initiated during a migraine attack is associated with meaningful improvement in patient-reported outcome measures: secondary results from the randomized controlled RELIEF study
    McAllister, Peter
    Winner, Paul K.
    Ailani, Jessica
    Buse, Dawn C.
    Lipton, Richard B.
    Chakhava, George
    Josiassen, Mette Krog
    Lindsten, Annika
    Mehta, Lahar
    Ettrup, Anders
    Cady, Roger
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (01):
  • [9] Eptinezumab treatment initiated during a migraine attack is associated with meaningful improvement in patient-reported outcome measures: secondary results from the randomized controlled RELIEF study
    Peter McAllister
    Paul K. Winner
    Jessica Ailani
    Dawn C. Buse
    Richard B. Lipton
    George Chakhava
    Mette Krog Josiassen
    Annika Lindsten
    Lahar Mehta
    Anders Ettrup
    Roger Cady
    The Journal of Headache and Pain, 2022, 23
  • [10] Reduced Impact of Headaches After Migraine Preventive Treatment with Eptinezumab in Patients with Chronic Migraine: Results from the PREVAIL Open-Label Safety Study
    Spierings, E.
    Biondi, D.
    Hirman, J.
    Horblyuk, R.
    Cady, R.
    HEADACHE, 2019, 59 : 36 - 36
123